Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-23T15:04:51.245Z Has data issue: false hasContentIssue false
  • English
  • Français

Amino acid precursors of monoamine neurotransmitters and some factors influencing their supply to the brain

Published online by Cambridge University Press:  09 July 2009

P. M. Daniel ,
S. R. Moorhouse  and
O. E. Pratt
P. M. Daniel*
Affiliation:
Department of Neuropathology, Institute of Psychiatry, London
S. R. Moorhouse
Affiliation:
Department of Neuropathology, Institute of Psychiatry, London
O. E. Pratt
Affiliation:
Department of Neuropathology, Institute of Psychiatry, London
*
1Address for correspondence: Dr P. M. Daniel, Department of Neuropathology, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF.
Get access Rights & Permissions [Opens in a new window]

Synopsis

There is evidence that changes in the concentrations of the monoamine neurotransmitters within the brain are associated with changes in mental processes, with disorders of control of movement and with certain neuropsychiatric diseases. These neurotransmitters are synthesized in the brain from aromatic amino acid precursors that have to be obtained from the circulating blood. In this study some factors which alter the rates of entry of four amino acids (the important neurotransmitter precursors L-tyrosine and L-tryptophan, as well as L-phenylalanine and L-histidine) into the brain have been studied and the findings considered in relation to conditions in which the quantities of one or more of the monoamine neurotransmitters formed within the cerebral cells may be either too large or too small. Thus too little neurotransmitter will be formed if competition between amino acids for the carriers transporting them into the cerebral cells causes the exclusion of a large proportion of any of the aromatic amino acid precursors from the brain. For example, L-tryptophan is partially excluded from the brain if a raised level of any one of several other amino acids is maintained in the circulation. Of these, L-phenylalanine inhibits the transport of L-tryptophan into the brain most effectively, while aromatic amino acids in general exclude L-tryptophan more effectively than do other neutral amino acids.

Over-production of one or more of the monoamine neurotransmitters is likely to occur when there is too much of one of the aromatic amino acid precursors in the brain cells as a result of abnormally high uptake from the blood, or as a result of their release by an excessive breakdown of the protein within these cells. Underproduction of neurotransmitters may occur in certain disease states, such as some aminoacidurias or Parkinsonism. We have listed some conditions associated with altered mental states or motor disability in which over- or under-production of monoamine neurotransmitters may occur and have tried to relate the findings in human disease with our experimental results.

Type
Research Article
Information
Psychological Medicine , Volume 6 , Issue 2 , May 1976 , pp. 277 - 286
Copyright
Copyright © Cambridge University Press 1976

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Abitbol, C. L., Feldman, D. B., Ahmann, P. & Rudman, D. (1975). Plasma amino acid patterns during supplemental intravenous nutrition of low-birth-weight infants. Journal of Pediatrics 86, 766–772.CrossRefGoogle ScholarPubMed
Baños, G., Daniel, P. M., Moorhouse, S. R. & Pratt, O. E. (1973). The influx of amino acids into the brain of the rat in vivo: the essential compared with some non-essential amino acids. Proceedings of the Royal Society 183, 59–70.Google ScholarPubMed
Baños, G., Daniel, P. M., Moorhouse, S. R. & Pratt, O. E. (1974 a). Inhibition of entry of some amino acids into the brain, with observations on mental retardation in the aminoacidurias. Psychological Medicine 4, 262–269.CrossRefGoogle ScholarPubMed
Baños, G., Daniel, P. M., Moorhouse, S. R., Pratt, O. E. & Wilson, P. (1974 b). Inhibition of neutral amino acid entry into the brain of the rat in vivo. Journal of Physiology 237, 22–23p.Google ScholarPubMed
Baños, G., Daniel, P. M. & Pratt, O. E. (1974 c). Saturation of a shared mechanism which transports L-arginine and L-lysine into the brain of the living rat. Journal of Physiology 236, 29–41.CrossRefGoogle ScholarPubMed
Baños, G., Daniel, P. M., Moorhouse, S. R. & Pratt, O. E. (1975). The requirements of the brain for some amino acids. Journal of Physiology 246, 539–548.CrossRefGoogle ScholarPubMed
Bernheimer, H. & Hornykiewicz, O. (1973). Brain amines in Huntington's chorea. In Barbeau, A., Chase, T. N. & Paulson, G. W. (eds)., Huntington's Chorea, 1872–1972: Advances in Neurology, vol. 1, pp. 525–531. Raven Press: New York.Google Scholar
Chase, T. N. (1974). Serotonergic–dopaminergic interactions and extrapyramidal function. In Costa, E., Gessa, G. L. & Sandler, Merton (eds.), Serotonin: New Vistas. Advances in Biochemical Psychopharmacology, vol. 11, pp. 377–385. Raven Press: New York.Google Scholar
Coppen, A., Shaw, D. M. & Farrell, J. P. (1963). Potentiation of the antidepressive effect of a monoamine–oxidase inhibitor by tryptophan. Lancet i, 79–81.CrossRefGoogle Scholar
Costa, E. (1973). Analysing kinetically the regulation of the turnover rate of putative neurotransmitters. In Sabelli, H. C. (ed.), Chemical Modulation of Brain Function, pp. 67–84. Raven Press: New York.Google Scholar
Crome, L. & Stern, J. (1972). Pathology of Mental Retardation. Churchill-Livingstone: Edinburgh and London.Google ScholarPubMed
Curtis, D. R. & Johnston, G. A. R. (1974). Amino acid transmitters in the mammalian central nervous system. Ergebnisse der Physiologie 69, 97–188.Google ScholarPubMed
Curzon, G. (1974). Availability of tryptophan to the brain and some hormonal and drug influences on it. In Costa, E., Gessa, G. L. & Sandler, Merton (eds.), Serotonin: New Vistas. Advances in Biochemical Psychopharmacology, vol. 10, pp. 263–271. Raven Press: New York.Google Scholar
Curzon, G., Joseph, M. H. & Knott, P. J. (1972). Effects of immobilization and food deprivation on rat brain tryptophan metabolism. Journal of Neurochemistry 19, 1967–1974.CrossRefGoogle ScholarPubMed
Curzon, G., Kantamaneni, B. D., Winch, J., Rojas-Bueno, A., Murray-Lyon, I. M. & Williams, R. (1973). Plasma and brain tryptophan changes in experimental acute hepatic failure. Journal of Neurochemistry 21, 137–145.CrossRefGoogle ScholarPubMed
Curzon, G. & Knott, P. J. (1975). Rapid effects of environmental disturbance on rat plasma unesterified fatty acid and tryptophan concentrations and their prevention by antilipolytic drugs. British Journal of Pharmacology 54, 389–396.CrossRefGoogle Scholar
Cusworth, D. C., Dubowitz, V. & Harvey, C. C. (1966). Hypermethioninaemia in acute tyrosinosis. Lancet i, 598–599.CrossRefGoogle Scholar
Daniel, P. M., Donaldson, J. & Pratt, O. E. (1974 a). The rapid achievement and maintenance of a steady level of an injected substance in the blood plasma. Journal of Physiology 237, 8–9 p.Google ScholarPubMed
Daniel, P. M., Donaldson, J. & Pratt, O. E. (1975 a). A method for injecting substances into the circulation to reach rapidly and to maintain a steady level. Medical and Biological Engineering 13, 214–227.CrossRefGoogle ScholarPubMed
Daniel, P. M., Love, E. R., Moorhouse, S. R., Pratt, O. E. & Wilson, P. (1974 b). A method for rapidly washing the blood out of an organ or tissue of the anaesthetized living animal. Journal of Physiology 237, 11–12 p.Google ScholarPubMed
Daniel, P. M., Love, E. R., Moorhouse, S. R. & Pratt, O. E. (1975 b). Amino acids, insulin, and hepatic coma. Lancet ii, 179–180.CrossRefGoogle Scholar
Daniel, P. M., Love, E. R. & Pratt, O. E. (1975 c). Hypothyroidism and amino acid entry into brain and muscle. Lancet ii, 872.CrossRefGoogle Scholar
Davis, J. N. & Carlsson, A. (1973). The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain. Journal of Neurochemistry 21, 783–790.CrossRefGoogle ScholarPubMed
Denckla, W. D. & Dewey, H. K. (1967). The determination of tryptophan in plasma, liver, and urine. Journal of Laboratory and Clinical Medicine 69, 160–169.Google ScholarPubMed
Essman, W. B. (1971). Drug effects and learning and memory processes. Advances in Pharmacology and Chemotherapy, 9, 241–330. Academic Press: New York and London.Google Scholar
Fernstrom, J. D. & Wurtman, R. J. (1971). Brain serotonin content: increase following ingestion of carbohydrate diet. Science 174, 1023–1025.CrossRefGoogle ScholarPubMed
Ghadimi, H. & Zischka, R. (1967). Histidinemia. In Nyham, W. L. (ed.), Amino Acid Metabolism and Genetic Variation. McGraw-Hill: New York.Google Scholar
Hornykiewicz, O. (1973). Dopamine in the basal ganglia: its role and therapeutic implications. British Medical Bulletin 29, 172–178.CrossRefGoogle ScholarPubMed
Knell, A. J., Davidson, A. R., Williams, R., Kantamaneni, B. D. & Curzon, G. (1974). Dopamine and serotonin metabolism in hepatic encephalopathy. British Medical Journal i, 549–551.CrossRefGoogle Scholar
Knell, A. J., Pratt, O. E., Curzon, G. & Williams, R. (1972). Changing ideas in hepatic encephalopathy. In Neale, G. (ed.), Eighth Symposium on Advanced Medicine, pp. 156–170. Pitman: London.Google Scholar
Knott, P. J. & Curzon, G. (1972). Free tryptophan in plasma and brain tryptophan metabolism. Nature 239, 452–453.CrossRefGoogle ScholarPubMed
Knott, P. J., Joseph, M. H. & Curzon, G. (1973). Effects of food deprivation and immobilization on tryptophan and other amino acids in rat brain. Journal of Neurochemistry 20, 249–251.CrossRefGoogle ScholarPubMed
Lajtha, A. (1970). Metabolic reactions in the nervous system. In Lajtha, A. (ed.), Handbook of Neurochemistry, vol. 3, ch. 6–11. Academic Press: New York and London.Google Scholar
Lewis, L. D., Ljunggren, B., Norberg, K. & Siesjö, B. K. (1974). Changes in carbohydrate substrates, amino acids and ammonia in the brain during insulin-induced hypoglycemia. Journal of Neurochemistry 23, 659–671.CrossRefGoogle ScholarPubMed
McArthur, J. N. & Dawkins, P. D. (1969). The effect of sodium salicylate on the binding of L-tryptophan to serum proteins. Journal of Pharmacy and Pharmacology 21, 744–750.CrossRefGoogle ScholarPubMed
McMenamy, R. H. & Oncley, J. L. (1958). The specific binding of L-tryptophan to serum albumin. Journal of Biological Chemistry 233, 1436–1447.CrossRefGoogle ScholarPubMed
Moir, A. T. B. & Eccleston, D. (1968). The effects of precursor loading in the cerebral metabolism of 5-hydroxy-indoles. Journal of Neurochemistry 15, 1093–1108.CrossRefGoogle Scholar
Neame, K. D. (1968). Transport, metabolism and pharmacology of amino acids in brain. In Davison, A. N. & Dobbing, J. (eds.), Applied Neurochemistry, pp. 119–177. Blackwell: Oxford.Google Scholar
Oldendorf, W. H. (1971). Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. American Journal of Physiology 221, 1629–1639.CrossRefGoogle ScholarPubMed
Oldendorf, W. H., Sisson, W. B. & Silverstein, A. (1971). Brain uptake of Selenomethionine Se 75. II. Reduced brain uptake of Selenomethionine Se 75 in phenylketonuria. Archives of Neurology 24, 524–528.CrossRefGoogle ScholarPubMed
Olney, J. W., Sharpe, L. G. & Feigin, R. D. (1972). Glut-amate-induced brain damage in infant primates. Journal of Neuropathology and Experimental Neurology 31, 464–488.CrossRefGoogle ScholarPubMed
Pratt, O. E. (1974). An electronically controlled syringe drive for giving an injection at a variable rate according to a preset programme. Journal of Physiology 237, 5–6 p.Google Scholar
Pratt, O. E. (1976). The transport of metabolizable substances into the living brain. In Levi, G., Battistin, L. & Lajtha, A. (eds.), Transport Phenomena in the Nervous System: Physiological and Pathological Aspects. Advances in Experimental Medicine and Biology, vol. 69, pp. 55–75. Plenum Press: New York.CrossRefGoogle Scholar
Schainker, B. & Olney, J. W. (1974). Glutamate-type hypo-thalamic-pituitary syndrome in mice treated with aspartate or cysteate in infancy. Journal of Neural Transmission 35, 207–215.CrossRefGoogle ScholarPubMed
Shoemaker, W. J. & Wurtman, R. J. (1971). Perinatal undernutrition: accumulation of catecholamines in rat brain. Science 171, 1017–1019.CrossRefGoogle ScholarPubMed
Shuster, L. & Hannam, R. V. (1964). The indirect inhibition of protein synthesis in vivo by chlorpromazine. Journal of Biological Chemistry 239, 3401–3406.CrossRefGoogle ScholarPubMed
Snyderman, S. E. (1975). Maple syrup urine disease. In Raine, D. N. (ed.), The Treatment of Inherited Metabolic Disease. Medical and Technical Publishing: Lancaster.Google ScholarPubMed
Sokoloff, L. (1967). Action of thyroid hormones and cerebral development. American Journal of Diseases of Children 114, 498–505.Google ScholarPubMed
Stanbury, J. B., Wyngaarden, J. B. & Fredrickson, D. S. (1972). The Metabolic Basis of Inherited Disease, 3rd ed.McGraw-Hill: New York.Google Scholar
Vogt, M. (1973). Functional aspects of the role of catecholamines in the central nervous system. British Medical Bulletin 29, 168–172.CrossRefGoogle ScholarPubMed
Wurtman, R. J., Larin, F., Mostafapour, S. & Fernstrom, J. D. (1974). Brain catechol synthesis: control by brain tyrosine concentration. Science 185, 183–184.CrossRefGoogle Scholar
Yudilevich, D. L., De Rose, N. & Sepulveda, F. V. (1972). Facilitated transport of amino acids through the blood–brain barrier of the dog studied in a single capillary circulation. Brain Research 44, 569–578.CrossRefGoogle Scholar